Medical device recalls Moderate risk

Ameditech Inc recalls Alere iCup Drug Detection (AMT Item Number/ AMT Description): I-DXA-10/ "Alere" iCup¿ Dx 10 Drug Detection + Adulterati…

Recall date
August 18, 2020
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-3031-2020
FDA classification
Class II
Brand / firm
Ameditech Inc
Sold / distributed
US - Nationwide OUS - Australia, France, Germany, New Zealand, Singapore and Spain

Why it was recalled

Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Alere iCup Drug Detection (AMT Item Number/ AMT Description): I-DXA-10/ "Alere" iCup¿ Dx 10 Drug Detection + Adulteration AMP/BAR/BZO/COC/MET/MDMA/MTD/MOP/OXY/THC Bl, Cr, Ni, pH, SG", I-DXA-13B/"Alere" iCup¿ DX Drug Screen Cup 13 Drug Detection + Adulteration AMP/BAR/BZO/BUPG/COC/MET/MDMA/MTD/MOP/OXY/PCP/THC/TCA Bl, Cr, Ni, pH, SG", I-DXA-1127-023-N "Alere" iCup¿ Dx Drugs of Abuse Test (COC/THC)+(MET1000/OPI2000)+(MTD/TCA)+ (OXY/MDMA)+(PCP/AMP)+BAR+BZO With Cr, Ni, pH, Bl, S.G."

Get recall alerts

Free email alert whenever Ameditech Inc has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Ameditech Inc